Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness
- 1 March 2025
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 328 (3) , L413-L429
Abstract
In patients suffering from systemic sclerosis (SSc), pulmonary arterial hypertension (PAH) is a life-threatening complication linked to immune dysregulation. Preclinical analyses in Fos-related antigen-2 (Fra-2) transgenic (TG) mice, a model of SSc-PAH, identify type 2 inflammation as a key driver of vascular remodeling. Anti-inflammatory treatment targeting type 2 inflammation via IL-13 neutralizing antibodies improved pulmonary vascular remodeling. Thus, type 2-specific anti-inflammatory treatment may be a promising therapeutic approach in SSc-PAH.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB1449 and SFB-TR84)
- Austrian Science Fund (T1032-B34)
- European Respiratory Society (STRTF 2015 - 9543)
- Austrian Science Fund (KLI 884-B)
This publication has 63 references indexed in Scilit:
- Retrospectively gated ultrashort‐echo‐time MRI T1 mapping reveals compromised pulmonary microvascular NO‐dependent function in a murine model of acute lung injuryNMR in Biomedicine, 2024
- Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic SclerosisArthritis & Rheumatology, 2022
- Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseasesCellular Signalling, 2019
- Pulmonary vascular remodeling in pulmonary hypertensionCell and tissue research, 2016
- Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertensionThe Journal of Pathology, 2014
- Flow velocity patterns in the pulmonary artery and pulmonary hypertensionCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2012
- The transcription factor Fra‐2 regulates the production of extracellular matrix in systemic sclerosisArthritis & Rheumatism, 2009
- Immunosuppressive therapy in lupus‐ and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty‐three casesArthritis & Rheumatism, 2008
- Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiographyThe American Journal of Cardiology, 1987
- Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterizationThe American Journal of Cardiology, 1986